Ashish Agrawal

Ashish Agrawal, MD is an Associate Clinical Professor at the University of California, San Francisco (UCSF), based at Zuckerberg San Francisco General Hospital. His clinical specialties include Critical Care Medicine, Respiratory Care, and Trauma. He completed a Diversity, Equity, and Inclusion Champion Training program through the University of California in 2019.

Dr. Agrawal's research focuses on biomarkers predictive of acute lung injury (ALI) and endothelial dysfunction in critically ill patients. His work emphasizes improving clinical prediction scores through plasma biomarkers like angiopoietin-2, which identifies high-risk patients early in their care.

His publications span critical care topics, including ALI pathogenesis, optic nerve sheath diameter measurement techniques, and corneal stem cell transplantation trials. He has contributed to studies funded by NIH grants (e.g., HL090833, HL110969).